Accelrys Announces Date of First Quarter, Fiscal 2005 Financial Results and Conference Call
SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- Accelrys, Inc. (Nasdaq: ACCL)
today announced that it plans to release its financial results for the quarter
ended June 30, 2004 after the NASDAQ Market closes on Thursday July 29, 2004.
The company will conduct a conference call and an audio webcast at 5:00 p.m.
EDT on the same day.
Mark Emkjer, President, and CEO will host the call. Forward-looking and
other material information may be discussed on this conference call.
Conference call numbers are as follows:
Domestic callers: 1-800-299-9086
International callers: 1-617-786-2903
Passcode: 79632078
Webcast information: http://www.accelrys.com/ir/meetings.html
A replay of the conference call, which can be accessed by dialing
toll-free 1-888-286-8010, and outside the U.S. 1-617-801-6888, will be
available for 2 weeks. The access code for the replay is 76642531.
About Accelrys, Inc.
Accelrys, Inc. (Nasdaq: ACCL) is the parent of Accelrys Software Inc., a
leading provider of software for computation, simulation, and the management
and mining of scientific data used by biologists, chemists and materials
scientists, including nanotechnology researchers for product design as well as
drug discovery and development. Accelrys technology and services are designed
to meet the needs of today's leading research organizations. The company is
headquartered in San Diego, California. For more information about Accelrys,
visit its website at http://www.accelrys.com/.
When used anywhere in this document, the words expects, believes,
anticipates, estimates, and similar expressions are intended to identify
forward-looking statements. Forward-looking statements herein may include
statements addressing future financial and operating results of Accelrys.
Accelrys has based these forward-looking statements on its current
expectations about future events. Such statements are subject to risks and
uncertainties including, but not limited to, the successful implementation of
Accelrys' strategic plans, the acceptance of new products, the obsolescence of
existing products, the resolution of existing and potential future patent
issues, additional competition, changes in economic conditions, and other
risks described in documents Accelrys has filed with the Securities and
Exchange Commission, including its most recent report on Form 10-K and
subsequent reports on Form 10-Q. All forward-looking statements in this
document are qualified entirely by the cautionary statements included in this
document and such filings. These risks and uncertainties could cause actual
results to differ materially from results expressed or implied by
forward-looking statements contained in this document. These forward-looking
statements speak only as of the date of this document. Accelrys disclaims any
undertaking to publicly update or revise any forward-looking statements
contained herein to reflect any change in its expectations with regard thereto
or any change in events, conditions or circumstances on which any such
statement is based.
CONTACT: John Hanlon, CFO, +1-858-799-5000, or Ian Clements, Director,
Corporate Communications, +1-858-799-5440, iclements@accelrys.com, both of
Accelrys, Inc.
SOURCE Accelrys, Inc.
More by this Source
New Release of Accelrys Electronic Lab Notebook Transforms Laboratory Operations
May 20, 2013, 08:00 ET
Accelrys Announces European Tech Summit 2013
May 09, 2013, 08:00 ET
Accelrys and Pfizer Extend Agreement for Global Deployment of Scientific Innovation Lifecycle Management Software
May 07, 2013, 08:00 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.





